NCT02990104

Brief Summary

The purpose of this study is to describe the incidence, clinic characteristics, biological and suvirval in Lymphoblastic Leukemia patients in Mexico City reference hospitals.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2016

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2016

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

December 5, 2016

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 13, 2016

Completed
19 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2017

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2017

Completed
Last Updated

December 13, 2016

Status Verified

November 1, 2016

Enrollment Period

2 months

First QC Date

December 5, 2016

Last Update Submit

December 7, 2016

Conditions

Acute Leukemia (Category)

Outcome Measures

Primary Outcomes (1)

  • Get the incidence of Acute Lymphoblastic Leukemia in Mexico City reference hospitals

    Date collection from clinical files with Acute Lymphoblastic Leukemia diagnostic between 2009 and 2013 in Mexico City in 5 reference hospitals

    5 years

Secondary Outcomes (1)

  • Clinic characteristics, biological and survival in Acute Lymphoblastic Leukemia patients in Mexico City reference hospitals

    5 years

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Acute Lymphoblastic Leukemia

You may qualify if:

  • Clinical diagnosis of Acute Lymphoblastic Leukemia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

Mexico City, Mexico Distrito Federal, 1400, Mexico

RECRUITING

Study Officials

  • Dr. Erick Crespo, Doctor

    Regional Hospital High Speciality, Tamaulipas Cd. Victoria

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Dra. Roberta Demichelis, Doctor

CONTACT

015554870900robertademichelis@gmail.com

Dra. Karla Espinoza, Doctor

CONTACT

015556280400

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 5, 2016

First Posted

December 13, 2016

Study Start

November 1, 2016

Primary Completion

January 1, 2017

Study Completion

July 1, 2017

Last Updated

December 13, 2016

Record last verified: 2016-11

Locations

ME(1)